Almac Diagnostics, as a stratified medicine company, specialises in biomarker driven clinical trials. Our global laboratories, in the UK and US, offer tailored diagnostic solutions from discovery to commercialisation: biomarker discovery, assay development & validation, CDx development & commercialisation. Your clinical trial diagnostic partner.
Clinical Trial Landscape
The clinical trial landscape for precision medicine has shifted significantly in recent years towards multiple biomarkers being used to select patients for multiple therapies (umbrella studies) or include patients from multiple cancer types (basket studies).
When multiple biomarkers are required in these types of studies, this usually involves complex logistics with multiple vendors and excessive sample requirements which can increase time to manage and cost to run.
Almac’s Clinical Trial Solutions
Almac Diagnostics has created novel panel solutions for multi-arm clinical trials – enabling clients to evaluate multiple biomarkers from one sample, whilst saving precious tissue, time and cost.
Almac offer a full portfolio of DNA and RNA assays which can be run using dual extraction from one FFPE sample. When combined, the assays provide a comprehensive review of tumour biology, the results of which are presented in an easily interpreted patient molecular data report which can be tailored to client requirements.
DNA Panel Solution – Almac clinical trial assay – Illumina TruSight® Tumor170 Cancer Panel
RNA Panel Solution – Almac optimised RUO workflow – Illumina TruSeq® RNA Exome Panel
For further information on our panels click on the options below: